When evaluating targeted therapies in chronic lymphocytic leukemia, the absolute measure of treatment effect should be preferred.
Saved in:
| Title: | When evaluating targeted therapies in chronic lymphocytic leukemia, the absolute measure of treatment effect should be preferred. |
|---|---|
| Authors: | Lévy, Vincent1,2 (AUTHOR) vincent.levy@aphp.fr, Lengline, Etienne1,3 (AUTHOR), Chevret, Sylvie1,4 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Jun2026, Vol. 67 Issue 7, p1527-1536. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10428194 |
|---|---|
| DOI: | 10.1080/10428194.2026.2647950 |
